Piper Jaffray Companies Reiterates “Buy” Rating for Humana Inc. (HUM)

Humana Inc. (NYSE:HUM)‘s stock had its “buy” rating reiterated by equities researchers at Piper Jaffray Companies in a research note issued on Friday. They currently have a $246.00 price objective on the insurance provider’s stock. Piper Jaffray Companies’ price target would suggest a potential upside of 3.55% from the company’s previous close.

Other research analysts also recently issued reports about the company. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $253.00 target price on the stock in a research note on Thursday, May 18th. BidaskClub downgraded Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Citigroup Inc. started coverage on Humana in a research note on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price on the stock. Jefferies Group LLC reiterated a “hold” rating and issued a $230.00 target price (up from $221.00) on shares of Humana in a research note on Thursday, May 4th. Finally, Evercore ISI reiterated an “outperform” rating and issued a $240.00 target price on shares of Humana in a research note on Tuesday, April 25th. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $231.00.

Shares of Humana (NYSE HUM) opened at 237.56 on Friday. Humana has a 12 month low of $150.00 and a 12 month high of $243.74. The stock has a market cap of $34.28 billion, a price-to-earnings ratio of 24.21 and a beta of 0.91. The company has a 50-day moving average price of $232.54 and a 200-day moving average price of $215.15.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.20. The firm had revenue of $13.76 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 14.38% and a net margin of 2.71%. During the same quarter last year, the business posted $1.86 EPS. On average, analysts expect that Humana will post $11.15 EPS for the current fiscal year.

WARNING: “Piper Jaffray Companies Reiterates “Buy” Rating for Humana Inc. (HUM)” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/2724522/piper-jaffray-companies-reiterates-buy-rating-for-humana-inc-hum.html.

In other news, SVP Brian P. Leclaire sold 4,971 shares of Humana stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the sale, the senior vice president now owns 14,258 shares of the company’s stock, valued at $3,421,920. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Bruce D. Broussard sold 118,231 shares of Humana stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $225.82, for a total value of $26,698,924.42. Following the completion of the sale, the chief executive officer now directly owns 171,170 shares of the company’s stock, valued at approximately $38,653,609.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 143,241 shares of company stock valued at $32,446,903. Insiders own 0.80% of the company’s stock.

Several large investors have recently made changes to their positions in the stock. Baldwin Brothers Inc. MA increased its stake in shares of Humana by 2.7% in the first quarter. Baldwin Brothers Inc. MA now owns 67,441 shares of the insurance provider’s stock worth $13,902,000 after buying an additional 1,782 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in shares of Humana by 6.3% in the fourth quarter. Thrivent Financial for Lutherans now owns 6,065 shares of the insurance provider’s stock worth $1,235,000 after buying an additional 360 shares in the last quarter. Orbis Allan Gray Ltd increased its stake in shares of Humana by 1.3% in the fourth quarter. Orbis Allan Gray Ltd now owns 1,308,615 shares of the insurance provider’s stock worth $266,997,000 after buying an additional 16,279 shares in the last quarter. ProShare Advisors LLC increased its stake in shares of Humana by 15.8% in the first quarter. ProShare Advisors LLC now owns 17,297 shares of the insurance provider’s stock worth $3,566,000 after buying an additional 2,356 shares in the last quarter. Finally, Capstone Asset Management Co. increased its stake in shares of Humana by 2.0% in the first quarter. Capstone Asset Management Co. now owns 16,805 shares of the insurance provider’s stock worth $3,464,000 after buying an additional 334 shares in the last quarter. 99.04% of the stock is owned by institutional investors and hedge funds.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.